Oxygen vs Air at Birth for Moderate- to Late-Preterm Infants

Importance The optimal initial fraction of inspired oxygen (F io 2 ) for delivery room resuscitation of neonates born at 32 to 35 weeks’ gestation is unknown. Objective To compare outcomes for neonates born at 32 to 35 weeks’ gestation when initiating resuscitation with F io 2 0.30 vs 0.21. Design, Setting, and Participants Unblinded, cluster randomized crossover trial in 26 Australian maternity hospitals, including tertiary, nontertiary, metropolitan, regional, public, and private sites, using a waiver of informed consent. All neonates born at participating sites at 32 to 35 weeks’ gestation without known major congenital anomalies who commenced respiratory support within 3 minutes of birth were enrolled from December 2022 to September 2025, with final follow-up in March 2026. Statistical analysis was conducted on October 29, 2025. Intervention Sites were randomly assigned to provide initial F io 2 of either 0.30 or 0.21 during the first 3 minutes of delivery room respiratory support. Sites crossed over to provide the alternative initial F io 2 halfway through their recruitment period. Main Outcomes and Measures The primary outcome was ongoing respiratory support when leaving the delivery room. Twelve secondary outcomes evaluated delivery room treatments and respiratory support until discharge. Results A total of 1818 eligible newborns (mean gestational age, 34.1 weeks; mean birth weight, 2165 g; 44.7% female) were included. Ongoing respiratory support when leaving the delivery room occurred in 700 of 964 newborns (72.6%) randomized to receive F io 2 0.30 and 626 of 854 newborns (73.3%) randomized to receive F io 2 0.21 (risk difference, −0.83 [95% CI, −4.33 to 2.67]). Of the 12 secondary outcomes, 10 were not significantly different between newborns randomized to receive F io 2 0.30 vs 0.21, while 2 were. Newborns randomized to receive F io 2 0.30 were less likely to receive higher levels of support in the delivery room, including noninvasive positive pressure ventilation (606 of 964 [62.9%] vs 560 of 854 [65.6%]), endotracheal or supraglottic airway ventilation (20 of 964 [2.1%] vs 24 of 854 [2.8%]), or cardiac compressions or epinephrine (19 of 964 [2.0%] vs 25 of 854 [2.9%]; proportional odds ratio, 0.70 [95% CI, 0.52-0.95]). Fewer newborns in the F io 2 0.30 group received endotracheal ventilation beyond the delivery room (61 of 959 [6.4%] vs 79 of 852 [9.3%]; risk ratio, 0.69 [95% CI, 0.47-0.91]). Conclusions and Relevance For neonates born at 32 to 35 weeks’ gestation, there was no difference between those commencing resuscitation with F io 2 0.30 vs F io 2 0.21 in the proportion still receiving respiratory support when leaving the delivery room. Trial Registration anzctr.org.au Identifier: ACTRN12621001267842

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-09-09
DOI
https://doi.org/10.1001/jama.2026.14201
Citations
1
Primary Topic
Neonatal Respiratory Health Research
Type
article
Field-Weighted Citation Impact
5.34
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Oxygen vs Air at Birth for Moderate- to Late-Preterm Infants

Wei Fan, Kavita Bhola, Emma Yeomans, Laura Mowat et al.
1 citations
JAMA
Neonatal Respiratory Health Research
5.34
article

Oxygen vs Air at Birth for Moderate- to Late-Preterm Infants

Wei Fan, Kavita Bhola, Emma Yeomans, Laura Mowat, Jeanie L.Y. Cheong, Alice Y.W. Fang, Georgina Bell, B. Manley, Maria G. Alda, Emily Reid, Daphne Anderson, Douglas A. Blank, Ansar Kunjunju, Ju Lee Oei, Sri Joshi, John F. Mills, Louise Owen, Archana Priyadarshi, Isaac R. Marshall, Laura Galletta, Datta Joshi, Niranjan Thomas, Hannah M Corcoran, Zhi Low, Anjali Dhawan, Joel Ziffer, Tejas N Doctor, D Stubbs, ASHWIJA UCHIL, Jubal John, Ho‐Yin Man, Timothy Walsh, Anneke C. Grobler, Koert de Waal, Tenille R Iskra, Hannah L Skelton, Catherine L Allgood, Kylie M. Yates, C. A. Niroshan Dombagahawaththage, Kalpesh F. Jain, Krystal Carman, Peter G. Davis, Sloane Birrell, Jessica C Costa-Pinto, James Pho, David J. Tickell, Pauline A Kazanis, Jane Nichol, Ma Luisa Lim, Stacey R. Peart, Kerryn A. Houghton, Mikael N A Dunlop, Arun Sasi, Lisa M Kalos, Paul D Machet, Calum T. Roberts, Nina R Ben-Menashe, Mark B. Tracy, Cecilia L. Moore, Emily R Harrison, Danielle G Coggan, Kate Booth, Jessica E Costello, Wendy Fonseka, Renae L. Allen, Melissa A Gallimore, Arlene Angela K Tan, Joanne E Pegg, Alison T Bale, Mark Norden, Katherine Parkhurst, Corinne A Boulter, Prasoon K. Goyadi, Neevan S Alavi, Tahlia Cowan, Emily Cahir, Anna Cartwright, Melissa Andrew, Erin E. M Church, Hannah J Lewis, Ally Blackburn, Rachel Brooks, Rachna Verma
article en
1 citations

Abstract

Importance The optimal initial fraction of inspired oxygen (F io 2 ) for delivery room resuscitation of neonates born at 32 to 35 weeks’ gestation is unknown. Objective To compare outcomes for neonates born at 32 to 35 weeks’ gestation when initiating resuscitation with F io 2 0.30 vs 0.21. Design, Setting, and Participants Unblinded, cluster randomized crossover trial in 26 Australian maternity hospitals, including tertiary, nontertiary, metropolitan, regional, public, and private sites, using a waiver of informed consent. All neonates born at participating sites at 32 to 35 weeks’ gestation without known major congenital anomalies who commenced respiratory support within 3 minutes of birth were enrolled from December 2022 to September 2025, with final follow-up in March 2026. Statistical analysis was conducted on October 29, 2025. Intervention Sites were randomly assigned to provide initial F io 2 of either 0.30 or 0.21 during the first 3 minutes of delivery room respiratory support. Sites crossed over to provide the alternative initial F io 2 halfway through their recruitment period. Main Outcomes and Measures The primary outcome was ongoing respiratory support when leaving the delivery room. Twelve secondary outcomes evaluated delivery room treatments and respiratory support until discharge. Results A total of 1818 eligible newborns (mean gestational age, 34.1 weeks; mean birth weight, 2165 g; 44.7% female) were included. Ongoing respiratory support when leaving the delivery room occurred in 700 of 964 newborns (72.6%) randomized to receive F io 2 0.30 and 626 of 854 newborns (73.3%) randomized to receive F io 2 0.21 (risk difference, −0.83 [95% CI, −4.33 to 2.67]). Of the 12 secondary outcomes, 10 were not significantly different between newborns randomized to receive F io 2 0.30 vs 0.21, while 2 were. Newborns randomized to receive F io 2 0.30 were less likely to receive higher levels of support in the delivery room, including noninvasive positive pressure ventilation (606 of 964 [62.9%] vs 560 of 854 [65.6%]), endotracheal or supraglottic airway ventilation (20 of 964 [2.1%] vs 24 of 854 [2.8%]), or cardiac compressions or epinephrine (19 of 964 [2.0%] vs 25 of 854 [2.9%]; proportional odds ratio, 0.70 [95% CI, 0.52-0.95]). Fewer newborns in the F io 2 0.30 group received endotracheal ventilation beyond the delivery room (61 of 959 [6.4%] vs 79 of 852 [9.3%]; risk ratio, 0.69 [95% CI, 0.47-0.91]). Conclusions and Relevance For neonates born at 32 to 35 weeks’ gestation, there was no difference between those commencing resuscitation with F io 2 0.30 vs F io 2 0.21 in the proportion still receiving respiratory support when leaving the delivery room. Trial Registration anzctr.org.au Identifier: ACTRN12621001267842

JAMA
Camden and Campbelltown Hospitals (AU), The University of Sydney (AU), Goulburn Valley Health (AU), Barwon Health (AU), Royal Women's Hospital (AU), Deakin University (AU), The University of Melbourne (AU), Northern Health (AU), Parks Victoria (AU), Royal Hospital for Women (AU), Epworth Hospital (AU), Royal North Shore Hospital (AU), Liverpool Hospital (AU), Mercy Hospital for Women (AU), Wollongong Hospital (AU), Breast Cancer Network Australia (AU), Frankston Hospital (AU), Blacktown & Mount Druitt Hospital (AU), Hudson Institute of Medical Research (AU), Westmead Hospital (AU), UNSW Sydney (AU), Illawarra Shoalhaven Local Health District (AU), Novita Healthcare (Australia) (AU), Eastern Health (AU), Monash Children’s Hospital (AU), Clinical Trial and Consulting (US), Ballarat Health Services (AU), Western Health (AU), Albury Wodonga Health (AU), St George Hospital (AU), John Hunter Children's Hospital (AU), Bendigo Health (AU), Murdoch Children's Research Institute (AU), Alfred Health (AU), National Health and Medical Research Council (AU), Casey Hospital, Monash University (AU), University of Newcastle Australia (AU)
Good health and well-being
Openalex Percentile: Top 3%
Neonatal Respiratory Health Research
5.34
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.